來氟米特|T1159|TargetMol

價(jià)格	￥187	￥314	￥527
包裝	10mg	25mg	50mg

最小起訂量	10mg
發(fā)貨地	上海
更新日期	2026-05-08

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:來氟米特	英文名稱:Leflunomide
CAS:75706-12-6	品牌: TargetMol
產(chǎn)地: 美國(guó)	保存條件: Keep away from moisture Powder: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
純度規(guī)格: 99.89%	產(chǎn)品類別: 抑制劑
貨號(hào): T1159

Product Introduction

Bioactivity

名稱	Leflunomide
描述	Leflunomide (HWA486) is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis.
激酶實(shí)驗(yàn)	DHODase activity is measured by the DCIP colorimetric assay. This is a coupled assay in which oxidation of DHO and subsequent reduction of ubiquinone are stoichiometrically equivalent to the reduction of DCIP. Reduction of DCIP is accompanied by a loss of absorbance at 610 nm (ε=21500 M/cm). The assay is performed in a 96-well microtiter plate at ambient temperature (ca. 25°C). Stock solutions of 10 mM leflunomide and A771726 are prepared in dimethyl sulfoxide (DMSO) and these are diluted with reaction buffer (100 mM Tris and 0.1 % Triton X-100, pH 8.0) to prepare working stocks of the inhibitors at varying concentrations. For each reaction, the well contained 10 nM DHODase, 68 μM DCIP, 0.16 mg/mL gelatin, the stated concentration of ubiquinone, 10 μL of an inhibitor working stock to give the stated final concentration, and reaction buffer. After a 5-min equilibration period, the reaction is initiated by addition of DHO to the stated final concentrations. The total volume of reaction mixture for each assay is 150 μL, and the final DMSO concentration is ≤ 0.01% (v/v). The reaction progress is followed by recording the loss of absorbance at 610 nm over a 10-min period (during which the velocity remained linear). Velocities are reported as the change in absorbance at 610 nm per minute, and each reported value is the average of three replicates. In experiments where the DHO or ubiquinone concentration is varied, the other substrate is held constant at 200 μM. To determine the inhibitor potency of leflunomide and A771726, the effects of varying concentrations of the two compounds on the initial velocity of the DHODase reaction is measured over a concentration range of 0.01?1.0 μM. In these experiments the DHO and ubiquinone concentrations are held constant at 200 and 100 μM, respectively.
體外活性	Leflunomide能夠防止和逆轉(zhuǎn)嚙齒動(dòng)物、狗、猴等體內(nèi)同種異體移植物和異種移植物排斥.
體內(nèi)活性	Leflunomide是一種免疫調(diào)節(jié)藥物,可通過抑制線粒體酶二氫乳清脫氫酶發(fā)揮作用。Leflunomide能夠抑制抗CD3-和白細(xì)胞介素-2（IL-2）刺激的T細(xì)胞增殖。Leflunomide也抑制抗CD3單克隆抗體刺激的反應(yīng),即人T淋巴細(xì)胞中IL-2產(chǎn)生和IL-2受體的表達(dá)。Leflunomide也抑制CTLL-4細(xì)胞中IL-2刺激的酪氨酸磷酸化。Leflunomide通過干擾由于rUMP產(chǎn)生不足和利用涉及p53的機(jī)制而引起的細(xì)胞周期進(jìn)展來阻止活化和自身免疫淋巴細(xì)胞的擴(kuò)增。Leflunomide在體外酪氨酸激酶測(cè)定中,能夠抑制p59fyn和p56lck活性。
存儲(chǔ)條件	Keep away from moisture Powder: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
溶解度	DMSO : 242.5 mg/mL (897.45 mM), Sonication is recommended. Ethanol : 27 mg/mL (99.92 mM), Sonication is recommended.
關(guān)鍵字	SU-101 \| SU 101 \| RS34821 \| RS 34821 \| Protein-tyrosine kinase 2 \| Leflunomide \| Inhibitor \| inhibit \| HWA-486 \| HWA 486 \| Dihydroorotate Dehydrogenase \| DHODH \| AhR
相關(guān)產(chǎn)品	Guanidine hydrochloride \| Glycerol \| Aceglutamide \| Malic acid \| DL-Lysine \| Sucrose \| Neomycin sulfate \| Dimethyl sulfoxide \| Sodium bicarbonate \| Gluconate Calcium \| Thymidine \| D(+)-Raffinose pentahydrate
相關(guān)庫(kù)	抗癌活性化合物庫(kù) \| 經(jīng)典已知活性庫(kù) \| 抗癌上市藥物庫(kù) \| 已知活性化合物庫(kù) \| EMA 上市藥物庫(kù) \| 臨床失敗化合物庫(kù) \| 抗衰老化合物庫(kù) \| FDA 上市藥物庫(kù) \| 免疫/炎癥分子化合物庫(kù) \| 藥物功能重定位化合物庫(kù) \| 抗癌臨床化合物庫(kù) \| 抗癌藥物庫(kù)

關(guān)鍵字：來氟米特|||SU101|||RS-34821|||HWA486|TargetMol

公司簡(jiǎn)介

上海陶術(shù)生物科技有限公司為美國(guó)Target Molecule Corp. ( Target Mol ) 在上海建立的全資子公司。我們與美國(guó)波士頓、德國(guó)慕尼黑的同事一起，為北美、歐洲和亞洲從事藥物研發(fā)和生物學(xué)研究的科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品和專業(yè)的服務(wù)。公司下設(shè)篩選事業(yè)部，化學(xué)事業(yè)部，生物事業(yè)部和新材料部。從虛擬篩選到實(shí)體化合物分子供應(yīng)；從商業(yè)化產(chǎn)品銷售到個(gè)性化定制合成；從對(duì)明確靶點(diǎn)的分子篩選到對(duì)明確分子的多靶點(diǎn)篩選，從高通量篩選到化學(xué)結(jié)構(gòu)優(yōu)化，我們都可以滿足您的科研用品及技術(shù)服務(wù)的需求。經(jīng)過在中國(guó)市場(chǎng)五年的精心耕耘，我們已成為篩選化合物領(lǐng)域優(yōu)秀的供應(yīng)商，為超過五百家學(xué)校和各類企業(yè)提供了品質(zhì)卓越的小分子化合物和藥物篩

成立日期	2013-04-18 （14年）	注冊(cè)資本	566.2651萬人民幣
員工人數(shù)	100-500人	年?duì)I業(yè)額	￥ 1億以上
主營(yíng)行業(yè)	化學(xué)試劑,生物活性小分子	經(jīng)營(yíng)模式	貿(mào)易,試劑,定制,服務(wù)

TargetMol中國(guó)（陶術(shù)生物）

VIP 14年

公司成立：14年
注冊(cè)資本：566.2651萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營(yíng)產(chǎn)品：小分子抑制劑，藥物篩選化合物庫(kù)，天然產(chǎn)物，活性分子化合物等
公司地址：上海市閘北區(qū)江場(chǎng)三路28號(hào)4樓

進(jìn)入店鋪

詢盤

店內(nèi)推薦

其他特殊品種庫(kù)

￥5000

其他特殊品種庫(kù)

￥5000

異鼠李素-3-O-葡萄糖苷|T5S1988|TargetMol

￥468